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1School of Chemistry, University of Leeds, Leeds, United KingdomABSTRACT One and the same protein can self-assemble into amyloid fibrils with different morphologies. The phenomenon of
fibril polymorphism is relevant biologically because different fibril polymorphs can have different toxicity, but there is no tool for
predicting which polymorph forms and under what conditions. Here, we consider the nucleation of polymorphic amyloid fibrils
occurring by direct polymerization of monomeric proteins into fibrils. We treat this process within the framework of our newly
developed nonstandard nucleation theory, which allows prediction of the concentration dependence of the nucleation rate for
different fibril polymorphs. The results highlight that the concentration dependence of the nucleation rate is closely linked
with the protein solubility and a threshold monomer concentration below which fibril formation becomes biologically irrelevant.
The relation between the nucleation rate, the fibril solubility, the threshold concentration, and the binding energies of the fibril
building blocks within fibrils might prove a valuable tool for designing new experiments to control the formation of particular fibril
polymorphs.INTRODUCTIONThe structure and mechanism of formation of amyloid fi-
brils are being widely researched, not only because they
are involved in many human diseases (1), but because of
their variety of applications as novel biomaterials in nano-
science (2). Although amyloid fibrils share a common
cross-b structure formed by intertwined layers of b-sheets
extending in a direction parallel to the fibril axis (3), the
conformation and the stacking of the b-strands in b-sheets
can differ in fibrils of the same protein, a phenomenon
known as fibril polymorphism (4–6). For example, stacking
polymorphism of fibrils has been observed in microcrystals
of short hexapeptides, where b-strands within b-sheets can
arrange in a parallel or antiparallel way, and the orientation
and stacking of b-sheets can differ (7). The stacking of b-
sheets in fibrils can also lead to differences in fibril thick-
ness, which in turn can lead to differences in the twisting
behavior and helical pitch of these fibrils, as has been
shown for fragments of bovine serum albumin (8) and the
TTR peptide (9). A well known example of conformational
polymorphism can be seen in fibrils of the amyloid b (Ab)
peptide associated with Alzheimer’s disease, which have
several distinct morphologies, including those where the
b-strands in the fibril adopt an extended or hairpin confor-
mation (10,11). The Ab fibrils also exhibit packing poly-
morphism, where the molecules are in the same
conformation but pack in the fibril with different stacking
or symmetry (11–13). Numerous examples of polymor-
phism can be found in fibrils of proteins including a-synu-Submitted September 5, 2014, and accepted for publication January 13,
2015.
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0006-3495/15/03/1176/11 $2.00clein (14), yeast and mammalian prion proteins (15,16), and
insulin (17) (more complete lists can be found in the liter-
ature (4–6,18)). The biological relevance of amyloid fibril
polymorphism comes from the observation that the toxicity
of polymorphs can differ (see, e.g., Tycko and colleagues
(11,19).). A prominent example is strain polymorphism
and species barriers in prions. In this phenomenon, the
prion protein can propagate multiple strains (fibril struc-
tures), each of which results in a different pathology. Prop-
agation is sequence-dependent, which prevents prion
transmission between related species (see, e.g., Jones and
Surewicz (15), Collinge and Clark (20), and Diaz-Avalos
et al. (21). The conditions under which fibril polymorphism
can be observed are manifold. Fibril morphology depends
on intrinsic factors such as the protein amino acid sequence,
and it has been observed that a single point mutation can
switch the fibril morphology from predominately parallel
to predominately antiparallel (22). It also depends on solu-
tion conditions (pH value (23) and salts (24)) and other
external factors (temperature (25), whether it is quiescent
or agitated (11), and seeds (26)), but even under the same
conditions, there are variations in fibril morphology (27).
How polymorphic amyloid fibrils form, and under what
conditions, is the subject of intense research (4–6). It is
generally accepted that amyloid fibrils form by a nucleation
and growth mechanism (see, e.g., Knowles et al. (28),
Lomakin et al. (29), and Kashchiev et al. (30)). The nucle-
ation of amyloid fibrils refers to the process of random gen-
eration of nanofibrils that have the ability to grow
irreversibly. Unless the nanofibril size exceeds the size of
the nucleus, the nanofibril is more likely to dissolve than
to grow. Depending on the solution conditions, amyloid fi-
brils nucleate in one step (directly from the solution) or inhttp://dx.doi.org/10.1016/j.bpj.2015.01.013
Amyloid Fibril Polymorphism 1177two steps (where step one is the appearance of nonfibrillar
oligomers in the solution and step two is the oligomer con-
version into fibrils) (31). In analogy to crystal nucleation
where the structure of the nucleus determines the structure
of the bulk solid, the structure of the fibril nucleus might
determine the structure of the fibril formed in the solution.
This implies that every fibril polymorph requires a distinct
nucleation event and certain nucleation events may occur
more frequently than others. Amyloid fibril growth refers
to the process of addition of monomers to either the fibril
ends or fibril surfaces, leading to lengthening and thick-
ening, respectively, of the fibril. During growth, fibrils can
be affected by other processes, such as fragmentation
(11,28), coalescence, Ostwald ripening, and secondary
nucleation events such as the nucleation of fibrils on the sur-
face of existing ones (32). Although a common feature of
fibril polymorphism is that they are self-propagating, such
growth effects can also lead to the formation of fibril poly-
morphs or determine which polymorph dominates. For
example, fibril coalescence and Ostwald ripening can lead
to fibrils with different thickness and thus different twisting
behavior and helical pitch, as in the case of bovine serum al-
bumin (8) and the TTR peptide (9) mentioned above. It has
also been shown that the fragmentation rate is the reason
that Ab40 fibrils with twofold symmetry form in agitated
solutions and Ab40 fibrils with three-fold symmetry form
in the absence of shear (11).
To better understand why and how polymorphic amyloid
fibrils form, and under what conditions, it is necessary to
develop a theoretical model of their formation.Models based
on protein physicochemical properties have been developed
to predict aggregation propensities, but they are unable to
differentiate between polymorphic fibril structures (33–36).
In a similar way, models on the molecular level based on
rate equations have been used to analyze protein fibrillation
experiments (28,37,38), but they are also unable to differen-
tiate between polymorphic fibril structures, because they
work with a fixed fibril shape. Fibril polymorphism has
been investigated in various molecular dynamics (MD)
simulation studies that use a full atomistic description of
proteins (39–43), but at present these studies are restricted
to calculations of the thermodynamic stability of fibrils
composed of short peptide fragments. Using a simplified pro-
tein model, it has been possible to perform MD simulations
showing that one protein can self-assemble into different
fibril morphologies, and that their formation can be kineti-
cally (rather than thermodynamically) controlled (44).
Here, we approach the problem by considering the nucle-
ation of amyloid fibrils into polymorphic structures when
the process occurs in one step by direct polymerization of
monomers into fibrils. Two-step nucleation of polymorphic
fibrils, and fibril polymorphism that occurs during fibril
growth, or is determined by fibril growth, are not consid-
ered. Recently, our simulations showed that amyloid fibril
nucleation occurring by direct polymerization of monomersis a peculiar kind of nucleation that does not comply with
standard nucleation theory (45,46), because the concept of
the existence of a critical nucleus breaks down (the nucleus
size does not have a unique value) and there exist jumps in
the nucleation rate of many orders of magnitude at certain
concentrations (47,48). This called for the development of
a new description of amyloid fibril nucleation that is able
to describe this nonstandard nucleation of amyloid fibrils
(30,49). The objective of this article is to apply this new
nucleation model to the phenomenon of amyloid fibril poly-
morphism and to predict how the fibril solubility, the
threshold concentration below which fibril formation be-
comes biologically irrelevant, and the nucleation rate are
affected by changes in the conformation and stacking of
the fibril building blocks (the b-strands) or their arrange-
ment within the fibril. Our considerations of fibril polymor-
phism pertain to changes in 1) the b-strand length associated
with the onset of polyglutamine disorders (50); 2) the
conformation of the b-strand from extended to hairpin re-
ported for Ab40 (10); 3) the parallel and antiparallel stacking
of b-strands in b-sheets, as observed in short peptides and
natural proteins (7,22); and 4) the asymmetry in hydropho-
bicity between the two b-sheet surfaces, which can lead to
different stacking of b-sheets in fibrils (7). The emphasis
of this work is to reveal general rules that underlie the nucle-
ation of one and the same protein into different fibril poly-
morphs and to provide conceptual insight into factors that
can tip the nucleation process in favor of one or another
fibril polymorph. For this reason, we apply our theoretical
framework to a model peptide rather than to a specific
protein.MATERIALS AND METHODS
Model
In our model (30,49,51), each b-strand (a segment of a protein chain
composed of typically up to 10 amino acids) is represented by a right rect-
angular prism (Fig. 1). Due to their strong hydrogen bonds, the b-strands
can arrange themselves laterally into b-sheets. The sheets consist of
different numbers m of b-strands (m ¼ 1; 2; 3;.) and are parallel to the
fibril lengthening axis. Along its thickening axis, the fibril is built up of
ib-sheets (i ¼ 1; 2; 3;.) held together by, for example, relatively weak hy-
drophobicity-mediated bonds between the b-strands. Because the orienta-
tion of side chains within a b-strand alternates, the hydrophobicity of the
two b-sheet surfaces is generally different. In our model (49), we assume
that for a 1b-sheet, i.e., a single b-sheet, the strongly hydrophobic (SH) sur-
face is always on top, as indicated by the red surface/line in Fig. 1, whereas
the weakly hydrophobic (WH) surface is at the bottom (Fig. 1, blue surface/
line). In addition, a b-strand can only bind to a WH b-sheet surface with its
WH side (blue binds to blue) and to an SH b-sheet surface with its SH side
(red binds to red). Thus, the hydrophobicity of the surface of a nanofibril
alternates as the number of b-sheets increases (red, blue, red, blue, etc.).
Since the fibril width is fixed and equal to the b-strand length, the fibril
can be considered as a two-dimensional (2D) aggregate in the m,i plane,
with building blocks (the b-strands) arranged in a 2D lattice with simple
rectangular symmetry.
Essential parameters in our theory to describe the ontogenesis of the
smallest nanosized amyloid fibrils are the dimensionless specific surfaceBiophysical Journal 108(5) 1176–1186
FIGURE 1 Phase diagram for fibrils composed of b-strands with oneWH
(blue) and one SH (red) side. The fibril solubility, Ce, indicates the concen-
tration ranges in which the protein solution is in stable (0%C1%Ce) or
metastable (C1>Ce) thermodynamic equilibrium at a given temperature.
(a) In the metanucleation range (i ¼ 0), the nucleus is a single b-strand.
In the first (i ¼ 1) nucleation range, a 2b-sheet with two WH surfaces
can elongate and the nucleus is a 1b-sheet with one b-strand attached
with its SH side to the SH 1b-sheet surface. In a similar way, in the second
nucleation range (i ¼ 2), a 3b-sheet with one SH and one WH surface can
elongate, and the nucleus is a 2b-sheet with one b-strand attached with its
WH side to the weak 2b-sheet surface. (b) As in (a), but in the first (i ¼ 1)
and second (i ¼ 2) nucleation ranges, the fibril nuclei are 1b- and 2b-sheets
(with two SH surfaces) with one b-strand attached to the WH and SH sides,
respectively. To see this figure in color, go online.
1178 Auerenergies j ¼ as=kT ¼ E=2kT and jw ¼ ahsw=kT ¼ Ew=2kT; js ¼
ahss=kT ¼ Es=2kT of the fibril faces perpendicular to the lengthening m
axis and the thickening i axis, respectively. s represents the dimensional
specific surface energy of the fibril surfaces, a the areas of the b-strand faces
(Fig. 1), k the Boltzmann constant, and T the absolute temperature. The sec-
ond equality in these equations results from using the approximate relations
s ¼ E=2a; ss ¼ Es=2ah, and sw ¼ Ew=2ah between s and the binding en-
ergy, E, between nearest-neighbor b-strands (52).
To model conformational polymorphism of b-strands within fibrils, it is
necessary to introduce the binding energies ε and εs, εw between nearest-
neighbor amino acids due to hydrogen bonding, and to strong and weak
hydrophobic bonding, respectively. Although our model can be applied to
heteropolypeptides, in this work, for simplicity, we consider only homopo-
lypeptides for which the binding energies between amino acids in neigh-
boring b-strands are the same. Then, E can be written as E ¼ nε,
Es ¼ nsεs, and Ew ¼ nwεw, where n is the number of amino acids between
two nearest-neighbor b-strands in a b-sheet that form hydrogen bonds, and
ns, nw are the number of amino acids that form strong and weak hydropho-
bic bonds, respectively, between nearest-neighbor b-strands in successive
b-sheets. The dimensionless specific surface energies js and jw can then
be written as
js ¼ nsas (1)Biophysical Journal 108(5) 1176–1186jw ¼ nwaw; (2)where as ¼ εs=2kT and aw ¼ εw=2kT are the dimensionless specific sur-
face energies per amino acid due to strong and weak hydrophobic bonds,
respectively.
It is important to note that the dimensionless specific surface energy, j,
can contain contributions from both nearest-neighbor hydrogen bonding
and hydrophobicity-mediated bonds and is given by
j ¼ naþ csnsas þ cwnwaw; (3)
where a ¼ ε=2kT represents the dimensionless specific surface energies per
amino acid due to hydrogen bonds, and cs, cw are parameters determiningthe contributions of the strong- and weak-hydrophobicity-mediated bonds,
respectively, to j. For our illustrations, we set cs ¼ cw ¼ 0:5, which means
that the contribution of the strength of the hydrophobicity-mediated bonds
to j is taken to be the average of the weak and strong hydrophobic surfaces.
To calculate js, jw and j for hetero polypeptides, the binding energies
between amino acid pairs need to be known so that the dimensionless spe-
cific surface energies can be calculated by summation over amino acid pairs
in neighboring b-strands (53).Phase diagram
Understanding the thermodynamic phase diagram is a prerequisite for
applying nucleation theory to the formation of new phases. Experiments
with different fibril polymorphs of Ab40 show that their solubility differs
(13,54). Both theoretical considerations (30,49,51) and a computer-simu-
lated peptide solubility diagram (55,56) reveal that for the irreversible elon-
gation of differently thick amyloid fibrils, thermodynamics requires
different ranges of the concentration C1 of monomeric b-strands (peptides
or protein segments) in the solution. Fig. 1 illustrates schematically these
ranges at a fixed absolute temperature, T, at which the b-strands are in prac-
tically fully extended conformation. These ranges are limited by the equi-
librium concentration (or solubility), Ce, of the bulk fibrillar phase and
the equilibrium concentrations (or solubilities) C1b, C2b;w, C2b;s, C3b, etc.,
of the fibrils constituted of one b-sheet, two equally long b-sheets with
two WH or two SH surfaces, three equally long b-sheets, etc., respectively.
The solubilities are merely the C1 values at which the respective ib-sheets,
i.e., fibrils built up of i b-sheets, neither lengthen nor dissolve. The ib-sheets
with an odd number i of layers have always one WH and one SH surface,
and their solubility, Cib, is related to Ce by the expression (49)
Cib ¼ Ceexp½ðjw þ jsÞ=i ði ¼ 1; 3; 5;.Þ: (4)
The existence of two solubility values for ib-sheets with an even number i
of layers is due to the fact that they can have either two WH or two SH sur-faces, and their solubilities Cib;w and Cib;s are related to Ce by the expres-
sions (49)
Cib;w ¼ Ceexpð2jw=iÞ (5)
Cib;s ¼ Ceexpð2js=iÞ; (6)
with (i ¼ 2; 4; 6;.). In this work, we mostly consider the symmetric case
where the hydrophobicity of both b-strand surfaces is the same, i.e.,
jw ¼ jshjh, and the three equations above simplify to one (51):
Cib ¼ Cib;w ¼ Cib;s ¼ Ceexpð2jh=iÞ ði ¼ 1; 2; 3;.Þ:
(7)
As indicated in Fig. 1, the C1>C1b range (range i ¼ 0 in the figure) corre-
sponds to metanucleation, a process of fibril formation without energy bar-rier, because then each protein monomer (i.e., single b-strand) in the
Amyloid Fibril Polymorphism 1179solution acts as a fibril nucleus since attachment of another monomer to it
allows irreversible elongation. When C1>C2b;w, 2b-sheets with two weak
hydrophobic surfaces can lengthen irreversibly. It is important to note
that in the C2b;w<C1<C1b range (Fig. 1, i ¼ 1), the 1b-sheets tend to
dissolve and their appearance is due to fluctuations. In this range, the fibril
nucleus is a 1b-sheet plus one b-strand attached with its SH side to the SH
1b-sheet side, so that a fibril prenucleus is any of the randomly formed,
differently long 1b-sheets in the solution. When C1>C2b;s, the 2b-sheets
with two strong hydrophobic surfaces also can lengthen irreversibly, and
in the C2b;s<C1<C1b range (Fig. 1, i ¼ 1) the corresponding fibril nucleus
is a 1b-sheet plus one b-strand attached with its WH side to the WH 1b-
sheet side (see Fig. 1). The situation is analogous to that of the 3b-sheets
when C1>C3b, because then these sheets can elongate irreversibly, and in
the C3b<C1<C2bw or C3b<C1<C2bs ranges (Fig. 1, range i ¼ 2), the fibril
nucleus is a 2b-sheet with one b-strand attached sidewise.
The general rules are, therefore, that in the ith supersaturation range,
defined by (49)
Ceexp½2jw=ðiþ 1Þ<C1<Ceexp½ðjw þ jsÞ=i (8)
Ceexp½2js=ðiþ 1Þ<C1<Ceexp½ðjw þ jsÞ=i (9)(i ¼ 1; 3; 5;.), the fibril nuclei are composed of an odd number i of b-
sheets plus one b-strand attached to the SH or WH side, respectively
(Fig. 1). In these ranges, all different-length ib-sheets are fibril prenuclei,
and these sheets plus one ib-strand attached to the WH or SH surface are
the fibril nuclei for the (i þ 1)b-sheet-thick fibrils with either two WH or
SH sides that can lengthen irreversibly. In a similar way, in the ith supersat-
uration range, defined by
Ceexp½ ðjw þ jsÞ=ðiþ 1Þ<C1<Ceexpð2jw=iÞ (10)
Ceexp½ ðjw þ jsÞ=ðiþ 1Þ<C1<Ceexpð2js=iÞ (11)(i ¼ 2; 4; 6;.), the fibril nuclei are composed of an even number i of b-
sheets plus one b-strand attached to the SH or WH side, respectively
(Fig. 1). For the symmetric case (js ¼ jwhjh), the four equations above
simplify to one general rule that in the ranges (51)
Ceexp½2jh=ðiþ 1Þ<C1<Ceexpð2jh=iÞ (12)
(i ¼ 0; 1; 2; 3;.), all differently long ib-sheets are fibril prenuclei, and
these sheets plus one b-strand attached to one of their two sides are the
nuclei of the (iþ 1)b-sheet-thick fibrils that can lengthen irreversibly.Nucleation rate
Which fibrils form in a protein solution, and how fast they do so, is deter-
mined by the nucleation rate, J (m3 s1). Experiments on protein aggrega-
tion are often performed at fixed temperature, T, and based on the phase
diagram discussed above, we can write down expressions for J in the nucle-
ation and metanucleation ranges. The concentration dependence of the
nucleation rate in the metanucleation range (Fig. 1, i ¼ 0), in which each
monomer in the solution acts as fibril nucleus, is given by (49)
J ¼ A1C21

1 A2C11

(13)
(C1>C1b), where A1 ¼ 2ke=Ce, A2 ¼ Ceexpðjw þ jsÞ, ke is the attachment
frequency of monomers to one of the two hydrogen-bond sides of a given
monomer at equilibrium, Ce is the fibril solubility, and the threshold con-
centration, C1b, given by
C1b ¼ Ceexpðjs þ jwÞ; (14)is obtained from Eq. 4 with i ¼ 1. For the symmetric case (js ¼ jwhjh),
the constants simplify to (30) A1 ¼ 2ke=Ce, A2 ¼ Ceexpð2jhÞ, and
C1b ¼ Ceexpð2jhÞ.
The formula for J in the ith nucleation range when the fibril nuclei are
composed of an odd number (i ¼ 1; 3; 5;.) of b-sheets plus one b-strand
(corresponding to supersaturation ranges (i ¼ 1; 3; 5;.) is given by (49)
J ¼ A1Ciþ21
1 A2C11
1 A3Ci1
2; (15)
with A1 ¼ ð2ke=Ciþ1e Þexpð2ji jw þ jsÞ and A2 ¼ Ceexp½2jw=ðiþ 1Þ
(for Ceexp½2jw=ðiþ 1Þ<C1<Ceexp½ðjw þ jsÞ=i) or A1 ¼ ð2ke=Ciþ1e Þ
expð2ji js þ jwÞ and A2 ¼ Ceexp½2js=ðiþ 1Þ (for Ceexp½2js=
ðiþ 1Þ<C1<Ceexp½ðjw þ jsÞ=i when the b-strand is on the SH or WH
side, respectively, of the nucleus. The constant A3 is given by
A3 ¼ Cie exp½ðjw þ jsÞ in both cases.
When the fibril nuclei are composed of an even number i ¼ 2; 4; 6;. of
b-sheets plus one b-strand (supersaturation ranges i ¼ 2; 4; 6;.), the fibril
nucleation rate is again given by Eq. 15, but with A1 ¼
ð4ke=Ciþ1e Þexpð2jiÞ and A2 ¼ Ceexp½ðjw þ jsÞ=ðiþ 1Þ. As to the con-
stant A3, it is given by A3 ¼ Cie expð2jwÞ (for Ceexp½ðjw þ jsÞ=
ðiþ 1Þ<C1<Ceexpð2jw=iÞ) when the b-strand is on one of the prenucleus
two WH sides, or by A3 ¼ Cie expð2jsÞ (for Ceexp½ðjw þ jsÞ=
ðiþ 1Þ<C1<Ceexpð2js=iÞ) when the b-strand is on one of the nucleus
two SH sides. For the symmetric case, the fibril nucleation rate is again
given by Eq. 15, but with A1 ¼ ð4ke=Ciþ1e Þexpð2jiÞ, A2 ¼ Ceexp½2jh=
ðiþ 1Þ, and A3 ¼ Cie expð2jhÞ in the supersaturation ranges specified
by Eq. 12.Fibril solubility
Different fibril polymorphs will have different solubilities (13,54). As the
effect of changing molecular interactions between b-strands on Ce is not al-
ways known experimentally, we estimate it theoretically by making use of
the van’t Hoff equation and the Haas-Drenth lattice model (57) for protein
crystals. The integrated van’t Hoff equation is given by Ce ¼ CrexpðlÞ,
where Cr is a practically temperature-independent reference concentration
and l ¼ L=kT is the dimensionless latent heat of peptide aggregation into
b-sheets. Here, L is the latent heat of peptide aggregation into such
aggregates. In the Haas-Drenth lattice model (57) for protein crystals, l
is half the dimensionless binding energy of peptides in the aggregates,
which is equivalent to the dimensionless broken bond energy
l ¼ 2jþ js þ jw at the periphery of a fibril in the m,i plane. The fibril sol-
ubility is then given by
Ce ¼ Crexpð  2j js  jwÞ (16)
and simplifies to Ce ¼ Crexp½2ðjþ jhÞ in the symmetric case.RESULTS
The recipe to apply our newly developed nonstandard nucle-
ation theory to predict the JðC1Þ dependence for different
fibril polymorphs is as follows. 1) Dimensionless specific
surface energies js, jw and j for different fibril polymorphs
are calculated from Eqs. 1–3. This requires knowledge of
the conformation of the b-strands in the fibril, as they define
the number, n, of bonds between amino acids, and the asso-
ciated binding energies between them. 2) Fibril solubility,
Ce, for different fibril polymorphs is calculated from
Eq 16. This requires the knowledge of Ce for one fibril poly-
morph, which serves as a reference structure. 3) The JðC1ÞBiophysical Journal 108(5) 1176–1186
1180 Auerdependence is calculated from Eqs. 13–15, which requires
knowledge of the elongation rate, ke. We apply this recipe
to the fibril polymorphs illustrated in Fig. 2. As mentioned
in the Introduction, the emphasis of this work is to provide
conceptual insight into factors that can tip the nucleation
process in favor of one or another fibril polymorph. For
this reason, we apply our theoretical framework to a model
peptide rather than to a specific protein.Conformational polymorphism
Perhaps the simplest example of conformational polymor-
phism is where the numbers of amino acids in the b-strands
within a fibril differ. The b-strand length is relevant because
it has been associated with polyglutamine disorders (50).
Polyglutamine disorders are a class of nine neurodegenera-
tive disorders, including Huntington’s disease, that are asso-
ciated with the aggregation of polyglutamine repeats. The
hallmark feature of these diseases is that the onset of the dis-
ease correlates with the length of the polyglutamine repeats.
The aggregation and pathologies are typically observed
above a threshold of 35–40 repeats, and the longer the
repeat, the sooner the symptoms appear (50,58). To illustrate
the effect of the b-strand length on JðC1Þ dependence, we
consider b-strands composed of 9, 10, and 11 amino acids
(Fig. 2 a) that assemble in their fully extended conformation
in a nanosized amyloid fibril. Step 1 of the recipe is to deter-
mine the dimensionless specific surface energies. As the
structure of the b-strands in the fibril is fully extended, the
number, n, of amino acids that form hydrogen bonds be-
tween two nearest-neighbor b-strands in a b-sheet and the
numbers nw, ns of amino acids that form hydrophobic bondsa b
c d
Biophysical Journal 108(5) 1176–1186between two nearest-neighbor b-strands are the same and
given by n ¼ ns ¼ nw ¼ 9, 10, and 11 for b-strands of
length 9, 10, and 11, respectively. Assuming that the dimen-
sionless specific surface energy per amino acid due to
hydrogen-bonding is a ¼ 1 (corresponding to ε ¼ 2 kT, a
value in the range of hydrogen bonding energies measured
experimentally (59)), that the ones due to strong and weak
hydrophobic bonds are as ¼ aw ¼ 0:1 (corresponding to
εs ¼ εw ¼ 0:2 kT, a value typically used in protein simula-
tions (60)), and that the parameter cs ¼ cw ¼ 0:5, the values
for the dimensionless specific surface energies are obtained
from Eqs. 1–3 and given by j ¼ 9:9, js ¼ jw ¼ jh ¼ 0:9
for b-strands of length 9, j ¼ 11, js ¼ jw ¼ jh ¼ 1 for
b-strands of length 10, and j ¼ 12:1, js ¼ jw ¼ jh ¼ 1:1
for b-strands of length 11. These j values are in the range
of values estimated for short fibrils (31,56). Step 2 of the
recipe is to calculate the fibril solubility, Ce, for different
fibril polymorphs. Assuming that the fibril solubility for
fibrils composed of b-strands with 10 amino acids is
Ce ¼ 6:0 1021 m3 (¼ 10 mM) (see, e.g., Aggeli et al.
(61)), we calculate from Eq. 16 that Cr ¼ 1:6 1032 m3.
It is important to note that as the binding energies of b-
strands of different lengths within the fibrils are different,
their fibril solubilities are different as well (see Materials
and Methods). Assuming that Cr ¼ 1:6 1032 m3 is inde-
pendent of the length, and substituting Cr and the j and jh
values above in Eq. 16, the solubilities for fibrils composed
of 9- and 11-amino-acid peptides are Ce ¼ 6:62 1022 m3
(¼ 110 mM) and Ce ¼ 5:41 1021 m3 (¼ 0.9 mM), respec-
tively. Fig. 3 a illustrates the obtained (exponential)
decrease of Ce with increasing length (Eq. 16). Step 3 of
the recipe is to calculate the JðC1Þ dependence for theFIGURE 2 Illustration of fibril polymorphs
considered in this work. (a and b) Conformational
polymorphism where the fibril polymorphs are
composed of extended b-strands of different lengths
(9 or 11 amino acids) (a) and b-strands in an
extended or hairpin conformation (b). (c and d)
Stacking polymorphism where the fibril poly-
morphs are composed of extended b-strands that
stack either parallel or antiparallel in b-sheets (c),
and b-sheets that stack by binding either with their
two WH or with their two SH surfaces (d). Red and
blue surfaces indicate the SH and WH b-strand
sides, respectively. Light gray and light orange sur-
faces indicate the strong- and weak-hydrogen-
bonding b-strand sides, respectively. To see this
figure in color, go online.
a b
c d
FIGURE 3 Solubility, Ce (diamonds), and
threshold concentration, C1b (crosses), of fibrils of
different compositions, as follows. (a) Extended
b-strands of length 9, 10, and 11 amino acids.
The corresponding values for the dimensionless
surface energies are jh ¼ 0:9, 1, and 1.1 and
j ¼ 9:9, 11, and 12.1 for strand lengths of 9, 10,
and 11, respectively. (b) Extended b-strands and
b-strands in a hairpin conformation. The corre-
sponding surface energies are j ¼ 11 (for both)
and jh ¼ 1 (extended) or 0.5 (hairpin). (c)
Extended b-strands in a parallel and an antiparallel
arrangement. The corresponding surface energies
are jh ¼ 1 (for both) and j ¼ 10 (antiparallel) or
11 (parallel). (d) Extended b-strands with asym-
metric hydrophobic surfaces between b-sheets.
The corresponding values for the dimensionless
surface energies are js ¼ 1 (for all) and j ¼ 11,
10.75 and jw ¼ 1, 0.5 for the symmetric and the
asymmetric hydrophobic surfaces, respectively.
For all compositions shown, the solid red and black
lines are obtained from Eqs. 14 and 16, respec-
tively. To see this figure in color, go online.
Amyloid Fibril Polymorphism 1181different fibril polymorphs. Using a typical value for the
fibril elongation rate, ke ¼ 104 s1 (see, e.g., Knowles
et al. (28)), and assuming that it is independent of the length,
allows us to calculate the JðC1Þ dependence from Eqs. 13–
15 with the A values for the symmetric case (because
js ¼ jwhjh). As can be seen in Fig. 4 a, the characteristic
feature of the JðC1Þ dependence is the sharp rise at the tran-
sition concentrations, Cib, over a very narrow concentration
range; the rise is 7 orders of magnitude at the nucleation/
metanucleation border C1b and even more at C2b. As
mentioned in the Introduction, such a sharp rise in the nucle-
ation rate is a peculiar kind of nucleation and does not
comply with standard nucleation theory (30). The impor-
tance of C1b comes from the fact that it appears as a
threshold concentration below which fibril formation be-
comes biologically irrelevant, because only one fibril can
be nucleated within a day in volumes of ~1 mm3 or smaller,
comparable to that of a cell. Fig. 4 a also shows that the
main effect of increasing the b-strand length on JðC1Þ
dependence is to shift C1b to lower concentrations and to
promote protein fibrillation, because metanucleation com-
mences at lower C1 values. Using the Ce values calculated
above in Eq. 14, the threshold concentrations for fibrils
with 9, 10, and 11 amino acids are C1b ¼ 4:0 1023 m3
(665.5 mM), C1b ¼ 4:4 1022 m3 (73.8 mM), and
C1b ¼ 4:9 1021 m3 (8.1 mM), respectively (Fig. 3 a).
The dependence of C1b on Ce (Eq. 14), however, highlights
that Ce is the determining factor in amyloid fibril nucleation
and is the main reason why fibrils composed of longer b-
strands nucleate faster. Even though we have considered
here only a short model peptide, the prediction that the
nucleation rate increases with increasing b-strand length iscompatible with the experimental observation that the onset
of the disease correlates with the length of the polyglut-
amine repeats (50).
Another example of conformational polymorphism in
amyloid fibrils has been reported for the amyloid-b peptide
where the Ab40 peptide is in the extended and the hairpin
conformation (10,12). To investigate how such a change in
the conformation affects JðC1Þ dependence, we consider fi-
brils composed of b-strands with 10 amino acids in an
extended conformation (as above) and a hairpin conforma-
tion (Fig. 2 b). The main difference for fibrils composed
of b-strands in a hairpin conformation is that only half of
the amino acids of the b-strand contribute to the hydropho-
bicity-mediated bonds between successive b-sheets, and
therefore, ns ¼ nw ¼ n=2 ¼ 5. All other parameters are
the same (i.e., a ¼ 1, aw ¼ as ¼ 0:1, and cw ¼ cs ¼ 0:5).
As in the previous example, the values for the dimensionless
surface energies for fibrils composed of b-strands in a
hairpin conformation are obtained from Eqs. 1–3 and are
given by j ¼ 11, js ¼ jw ¼ jh ¼ 0:5 (step 1 of the recipe).
The value j ¼ 11 is the same for both fibril polymorphs, as
the number of hydrogen and hydrophobic bonds in the di-
rection of the fibril lengthening axis is the same. Again us-
ing Cr ¼ 1:6 1032 m3 with j ¼ 11, jh ¼ 0:5 in Eq. 16
shows that the conformational change shifts Ce ¼
1:63 1022 m3 (27.1 mM) to slightly higher concentra-
tions (see Fig. 3 b) (step 2 of the recipe). As in the previous
example, we calculate JðC1Þ dependence from Eqs. 13–15
with ke ¼ 104 s1 and the A values for the symmetric
case (step 3 of the recipe). Fig. 3 b shows that the main
effect of this conformational change is a small decrease of
JðC1Þ, mainly because the threshold concentrationBiophysical Journal 108(5) 1176–1186
a b
c d
FIGURE 4 Concentration dependence of the
nucleation rate, J, for fibrils of different composi-
tion. (a) Extended b-strands of length 9, 10, and
11 amino acids (as indicated). (b) Extended b-
strands and b-strands in a hairpin conformation
(as indicated). (c) Extended b-strands in parallel
and antiparallel arrangements (as indicated). (d)
Extended b-strands with symmetric and asym-
metric hydrophobic surfaces between b-sheets, as
indicated. In the asymmetric case, the labels WH
and SH indicate the nucleation rate where the fibril
nucleus is a 1b-sheet plus one b-strand attached to
the SH andWH sides of the sheet, respectively. The
corresponding values for the dimensionless surface
energies are as in Fig. 3. In all cases, the black and
red lines indicate the rate in the metanucleation and
nucleation ranges, respectively. To see this figure in
color, go online.
1182 AuerC1b ¼ 4:4 1022 m3 (73.8 mM) is unchanged. This can be
shown by substitution of Eq. 16 into Eq. 14, which elimi-
nates js;jw in the exponents of C1b, so that it only depends
on j. Thus, the shift of Ce to slightly higher concentrations
compensates the corresponding shift of C1b to lower ones.
The prediction that the nucleation rates of fibrils composed
of peptides in an extended b-strand and hairpin conforma-
tion differ only slightly might explain why both fibril struc-
tures have been observed experimentally (10,12).Packing polymorphism
We first consider packing polymorphism where b-strands
within b-sheets are in a parallel or antiparallel arrangement
(Fig. 2 c), as has been observed in fibrils of short peptides
and natural proteins (7,22). As before, the fibril building
block is the extended b-strands composed of 10 amino
acids. To distinguish between parallel and antiparallel stack-
ing, we assume that the hydrogen-bonding energy between
b-strands in a b-sheet is weaker when stacked in an antipar-
allel arrangement than when stacked parallel. Thus, for anti-
parallel stacking, we set the specific surface energy per
amino acid due to hydrogen bonding to a ¼ 0:9, which is
smaller compared to a ¼ 1 for parallel arrangement. All
other values for the model parameter are unchanged (i.e.,
cw ¼ cs ¼ 0:5 and ns ¼ nw ¼ n ¼ 10). The corresponding
value for the dimensionless surface energy due to hydrogen
bonding for antiparallel stacking is j ¼ 10 (calculated as
before), whereas the values for the surface energy due to hy-
drophobicity-mediated bonds are js ¼ jw ¼ jh ¼ 1, as
before (step 1 of the recipe). The fibril solubility
Ce ¼ 4:4 1022 m3 (74 mM) is obtained from Eq. 16Biophysical Journal 108(5) 1176–1186with Cr ¼ 1:6 1032 m3 (step 2 of the recipe), which
shows that a change in the arrangement of the b-strand in
a b-sheet from parallel to antiparallel shifts Ce to much
higher concentrations (Fig. 3 c). Assuming again that
ke ¼ 104 s1 is independent of the stacking, the JðC1Þ
dependence is calculated from Eqs. 13–15 with the A values
for the symmetric case (step 3 of the recipe), illustrating that
a change in the arrangement of the b-strands in a b-sheet
from parallel to antiparallel shifts C1b to higher concentra-
tion and that it hampers protein fibrillation, because metanu-
cleation commences at higher C1 values (Fig. 4 c). Using the
Ce value calculated above (Eq 14), the threshold concentra-
tion is C1b ¼ 3:3 1023 m3 (545 mM) (see Fig. 3 c). It is
worth noting that a mixture of parallel and antiparallel fibrils
in the protein solution can only be observed at concentra-
tions in the metanucleation range of both fibrils, i.e., when
C1>C1b ¼ 545 mM, and provided that the magnitude of
the metanucleation rates are comparable and sufficiently
high (see Fig. 4 c). It should be noted that as it is not known
a priori whether antiparallel stacking decreases the specific
surface energy per amino acid due to hydrogen bonding, we
could also have assumed that this stacking increases it, in
which case antiparallel fibrils would nucleate faster. The
general rule is, however, that increasing the specific surface
energy per amino acid due to hydrogen bonding promotes
protein fibrillation, and the strong effect on the JðC1Þ depen-
dence might explain that a single point mutation can switch
the fibril morphology from predominately parallel to pre-
dominately antiparallel (22).
Another example of packing polymorphism is when b-
sheets stack differently, as observed in short peptides (7).
Along its thickening axis, the fibril is built up of b-sheets
Amyloid Fibril Polymorphism 1183which are held together by, e.g., relatively weak hydropho-
bicity-mediated bonds between the b-strands. Because the
orientation of side chains within a b-strand alternates, the
hydrophobicity of the two b-sheet surfaces is generally
different. This asymmetry leads to fibrils that can have
either two strong and two weak, or one strong and one
weak, hydrophobic surfaces (Fig. 2 d), but which ones
form? As in our previous work (49), to model the effect of
asymmetry, we decrease the weak specific surface tension
per amino acid due to hydrophobic bonding between b-
strands in consecutive b-sheets to aw ¼ 0:05, with
as ¼ 0:1 kept constant. The values of all other parameters
are the same as for the extended b-strand with symmetric
hydrophobic surfaces (i.e., cs ¼ cw ¼ 0:5, ns ¼ nw ¼
n ¼ 10). The corresponding values for the dimensionless
surface energies are obtained from Eqs. 1–3 and are given
by js ¼ 1, jw ¼ 0:5, j ¼ 10:75 (step 1 of the recipe),
and the corresponding asymmetry ratio is jw=js ¼ 0:5.
The fibril solubility is again obtained from Eq. 16 and is
given by Ce ¼ 7:3 1022 m3 (27 mM) (step 2 of the
recipe). Thus, increasing the asymmetry (by decreasing
the asymmetry ratio) shifts Ce to higher concentrations
(Fig. 3 d). We calculate the JðC1Þ dependence from
Eqs. 13 and 15 with ke ¼ 104 s1 and the A values for
the asymmetric case (step 3 of the recipe). However, a char-
acteristic feature in this case is that in a given concentration
range there exist different fibril nuclei (see Fig. 1). In Fig. 4
d, we show that in the first nucleation range (Fig. 1, i ¼ 1),
the nucleation rate for fibrils where the fibril nucleus is a
single b-sheet plus one b-strand attached to the SH side
can be substantially higher than that where the b-strand is
attached to the WH side. This implies that in the concentra-
tion range C2b;w<C1<C2b;s there is a morphological selec-
tion, as only fibrils with two WH surfaces can grow,
whereas those with two SH surfaces cannot (see Fig. 1).
The values for C2b;w ¼ 2:7 1022 m3 (45 mM) and
C2b;s ¼ 4:4 1022 m3 (74 mM) are obtained from Eqs. 5
and 6. In Fig. 4 d, we also show the corresponding JðC1Þ
dependence for the symmetric case, where it can be seen
that the main effect of increasing the asymmetry (decreasing
jw at constantjs) is to shiftC1b to a higher concentration and
to hamper protein fibrillation, because metanucleation com-
mences at higher C1 values. Using the Ce values calculated
inEq. 14, the threshold concentration for fibrilswith asymme-
try ratios of 0.5 is C1b ¼ 7:3 1022 m3 (121 mM). A solu-
tion mixture containing fibrils with two strong and two weak
hydrophobic surfaces, and one strong and one weak hydro-
phobic surface, can only be observed at concentrations in
the metanucleation regime of all fibrils, i.e., when
C1>C1b ¼ 121mM, provided the magnitudes of the metanu-
cleation rates are comparable and sufficiently high (see
Fig. 4 d). Note that although the effect of asymmetry is due
to changes in the hydrophobicity (as in the case of the confor-
mational change from an extended b-strand to a hairpin), the
shift of Ce to higher concentrations does not compensate thecorresponding shift of C1b to lower ones. This is so because a
change in aw also changesj (see Eq. 3), which is not the case
when the conformation changes from an extended b-strand to
a hairpin. The effect of asymmetry on JðC1Þ dependence pro-
vides new insight into how a change in the side-chain-side-
chain interactions between the b-strands can lead to a change
in the stacking of b-sheets within fibrils (7).DISCUSSION
Fibrils solubility and polymorphism
The results obtained from this study highlight the important
role of the threshold concentration, C1b, and the fibril solubi-
lityCe in amyloid fibril nucleation, and they illustrate thatCe
is the determining factor, becauseC1b depends onCe (Eq. 14).
Describing the phenomenon of fibril polymorphism on the
basis of fibril solubility, Ce, and the threshold concentration,
C1b, provides an alternate view of this important problem and
opens new ways to control the formation of particular fibril
polymorphs experimentally by changing C1b and Ce. There-
fore, we express both quantities in terms of the binding en-
ergies between neighboring b-strands in the fibril. An
approximate relation between Ce and the binding energies
can be obtainedby subtitutingEqs. 1–3 intoEq. 16.This gives
Ce ¼ Crexp½  ðnεþ csnsεs þ cwnwεw þ nsεs=2
þ nwεw=2Þ=kT; (17)
where ε, εs, and εw are the binding energies between nearest-
neighbor amino acids due to hydrogen bonding and to strong
and weak hydrophobic bonds, respectively. The n values are
the corresponding numbers of these bonds, and cs and cw are
parameters determining the contributions of hydrophobici-
ty-mediated bonds. In a similar way, the dependence of
C1b on the binding energies is obtained by substitution of
Eqs. 1, 2, and 17 into Eq. 1:
C1b ¼ Crexp½  ðnεþ csnsεs þ cwnwεwÞ=kT: (18)
These two relatively simple equations allow us to under-
stand and rationalize the results obtained for the concentra-
tion dependence of the nucleation rate for different fibril
polymorphs in terms of changes in the binding energies.
First, we consider the conformational polymorphism due
to an increase of the b-strand length within fibrils. Figs. 3
a and 4 a illustrate that increasing the b-strand length de-
creases Ce and promotes protein fibrillation, because C1b
is shifted to much lower C1 values. The reason for this is
that increasing the b-strand length increases n, ns, and nw,
which decreases both Ce and C1b (Eqs. 17 and 18). As ε is
10 times larger than εs and εw, however, this decrease is
dominated by the increase in the binding energy due to
hydrogen bonds. Second, we consider the packing polymor-
phism due to parallel or antiparallel stacking of b-strands in a
b-sheet. Figs. 3 c and 4 c illustrate that a change in theBiophysical Journal 108(5) 1176–1186
1184 Auerstacking of the b-strands in a b-sheet from parallel to antipar-
allel increases both Ce and C1b and thereby hampers protein
fibrillation. This decrease is solely due to the decrease in the
hydrogen-bonding energy, as a change in the stacking
arrangement only lowers ε, whereas εs and εw are unchanged
(see Eqs. 17 and 18). Third, we consider the conformational
polymorphism due to a change in the conformation of the b-
strand from extended to hairpin. Figs. 3 b and 4 b illustrate
that this conformational change only increases Ce, whereas
C1b is unchanged, and consequently, protein fibrillation is
only slightly hampered. As this conformational change
only decreases the numbers ns and nw of hydrophobic con-
tacts between b-strands in consecutive b-sheets (and not n),
this effect is entirely due to a change in the hydrophobic bind-
ing energy (see Eqs. 17 and 18). Fourth, we consider the
packing polymorphism due to the asymmetry between the
weak and strong hydrophobic b-strand surfaces, which can
lead to different packing of b-sheets within fibrils. Figs. 3
d and 4 d show that increasing the asymmetry increases
both Ce and C1b, thereby hampering protein fibrillation.
This effect is also entirely due to a decrease in the hydropho-
bic binding energy between b-strands, since with increasing
asymmetry only εw is lowered, whereas ε and εs are un-
changed (see Eqs. 17 and 18). The morphological selection
between fibrils with twoWH and SH b-sheet surfaces occurs
thanks to the inequality C2b;w<C2b;s, and by substitution of
Eqs. 1, 2, and 17 into Eqs. 5 and 6, it can be shown that this
inequality is due to the fact that εw < εs.General rule
Consideration of these four examples reveals a general rule
underlying fibril polymorphism, namely, that changes in
the conformation of the fibril building blocks or their packing
that increase their binding energy within fibrils (due to both
hydrogen and hydrophobic bonds) lower the fibril solubility,
Ce, and hence the threshold concentration,C1b, which in turn
promotes protein fibrillation. In other words, the nucleation
rate of the fibril polymorphs composed of fibril building
blocks with higher binding energy is higher. Although this
rule seems intuitive, we show here that it naturally emerges
by treating the nucleation of amyloid fibrils into polymorphic
structures within our newly developed nonstandard nucle-
ation. The power of the theoretical framework presented
here is that it provides a tool for both qualitative and quanti-
tative prediction of which polymorph forms based on the
fundamental interactions between the fibril building blocks.Limitations
Finally, we emphasize that the results obtained above apply
to one-step fibril nucleation, i.e., when the monomeric
b-strands polymerize directly into fibrils, and that the anal-
ysis treats homogeneous nucleation of amyloid fibrils occur-
ring when nucleation-active foreign particles or substratesBiophysical Journal 108(5) 1176–1186are absent from the solution. Two-step nucleation of poly-
morphic fibrils and fibril polymorphism that occurs during
fibril growth or is determined by fibril growth are not consid-
ered. It is important to note that application of the general ex-
pressions for the fibril nucleation rate, J, as an explicit
function of the concentration to different fibril polymorphs
requires that the reference concentration, Cr, and the attach-
ment frequency, ke, of monomers to one of the two fibril ends
at equilibrium are constant. Furthermore, the relation be-
tween the fibril solubility and the binding energies is approx-
imate and pertains to sufficiently low temperatures. It should
also be mentioned that the entropy loss when a b-strand is
attached to the fibril is taken into account in our newly devel-
oped nonstandard nucleation model (30,49). This is so
because in contrast to classical nucleation theory, in the deri-
vation of the analytical expression for the nucleation rate, the
length distribution of fibril nuclei in the solution is consid-
ered (see Kashchiev et al. (30)). The remarkably good
description of simulation data for the nucleation rate by
our so-derived expression (see Fig. 5 of Kashchiev et al.
(30)) indicates that entropy effects are indeed well accounted
for. Entropy effects due to vibrations of the b-strand within
fibrils are not explicitly considered, but ideas of how to do
that can be found in Ferrone (62), and they could be the basis
of an important extension of our model. The entropic effects,
however, are automatically accounted for when experi-
mental data for Ce and j, jh are used.CONCLUSIONS
We conclude that the nucleation of polymorphic amyloid fi-
brils can be treated within our newly developed nonstandard
nucleation theory. This treatment allows the prediction of
JðC1Þ dependence for different fibril polymorphs, which
highlights the important role of the threshold monomer con-
centration, C1b, and the protein solubility, Ce. Experimental
studies of amyloids often focus on their structure, assembly
mechanism, and interactions with the biological environ-
ment. Not so many experiments focus on determining the
fibril solubility and how it changes with fibril structure
and amino acid sequence. Describing the phenomenon of
fibril polymorphism on the basis of fibril solubility, Ce,
and threshold concentration, C1b, opens up new ways to
design experimental strategies to stimulate or prevent the
formation of particular fibril polymorphs, and for this, our
approximate relations between Ce, C1b, and the binding en-
ergies between neighboring b-strands in the fibril (Eqs. 17
and 18) might prove a valuable tool.ACKNOWLEDGMENTSThe author thanks Dr Leandro Rizzi and Professor Dimo Kashchiev for
stimulating discussions during the course of this study and for their com-
ments on the manuscript.
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